DNA vaccination with heat shock protein 60 inhibits cyclophosphamide-accelerated diabetes

Journal of Immunology

Volumn 169, Issue 10, 2002, Pages 6030-6035

  Quintana, Francisco J ^a   Carmi, Pnina ^a   Cohen, Irun R ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYTOKINE; DNA VACCINE; GAMMA INTERFERON; HEAT SHOCK PROTEIN 60; HEAT SHOCK PROTEIN 65; INTERLEUKIN 10; INTERLEUKIN 5; LIPOPOLYSACCHARIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; CPG ISLAND; CYTOKINE RELEASE; DIABETES MELLITUS; DNA VECTOR; DRUG ACTIVITY; FEMALE; GENE CONSTRUCT; GENETIC CODE; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOPHARMACOLOGY; IMMUNOTHERAPY; LYMPHOCYTE PROLIFERATION; MOUSE; MYCOBACTERIUM; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTECTION; PROTEIN MOTIF; TH1 CELL; TH2 CELL; VACCINATION;

EID: 0037111430     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.169.10.6030     Document Type: Article

References (37)

1. Bach, J. F., and L. Chatenoud. 2001. Tolerance to islet autoantigens in type I diabetes. Annu. Rev. Immunol. 19:131.
2. Cohen, I. R. 1997. The Th1/Th2 dichotomy, hsp60 autoimmunity, and type I diabetes. Clin. Immunol. Immunopathol. 84:103.
3. Cohen, I. R. 1997. Questions about NOD mouse diabetes. Res. Immunol. 148:286.
4. Birk, O. S., D. Elias, A. S. Weiss, A. Rosen, R. van-der Zee, M. D. Walker, and I. R. Cohen. 1996. NOD mouse diabetes: The ubiquitous mouse hsp60 is β-cell target antigen of autoimmune T cells. J. Autoimmun. 9:159.
5. Tisch, R., X. D. Yang, S. M. Singer, R. S. Liblau, L. Fugger, and H. O. McDevitt. 1993. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature 366:72.
6. Kaufman, D. L., M. Clare-Salzler, J. Tian, T. Forsthuber, G. S. Ting, P. Robinson, M. A. Atkinson, E. E. Sercarz, A. J. Tobin, and P. V. Lehmann. 1993. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 366:69.
7. Wegmann, D. R., M. Norbury-Glaser, and D. Daniel. 1994. Insulin-specific T cells are a predominant component of islet infiltrates in pre-diabetic NOD mice. Eur. J. Immunol. 24:1853.
8. Bach, J. F. 2001. Immunotherapy of insulin-dependent diabetes mellitus. Curr. Opin. Immunol. 13:601.
9. Elias, D., D. Markovits, T. Reshef, R. van der Zee, and I. R. Cohen. 1990. Induction and therapy of autoimmune diabetes in the non-obese diabetic (NOD/Lt) mouse by a 65-kDa heat shock protein. Proc. Natl. Acad. Sci. USA 87:1576.
10. Elias, D., T. Reshef, O. S. Birk, R. van der Zee, M. D. Walker, and I. R. Cohen. 1991. Vaccination against autoimmune mouse diabetes with a T-cell epitope of the human 65-kDa heat shock protein. Proc. Natl. Acad. Sci. USA 88:3088.
11. Elias, D., A. Meilin, V. Ablamunits, O. S. Birk, P. Carmi, S. Konen-Waisman, and I. R. Cohen. 1997. Hsp60 peptide therapy of NOD mouse diabetes induces a Th2 cytokine burst and downregulates autoimmunity to various β-cell antigens. Diabetes 46:758.
12. Oldstone, M. B. 1988. Prevention of type I diabetes in nonobese diabetic mice by virus infection. Science 239:500.
13. Oldstone, M. B. 1990. Viruses as therapeutic agents. I. Treatment of nonobese insulin-dependent diabetes mice with virus prevents insulin-dependent diabetes mellitus while maintaining general immune competence. J. Exp. Med. 171:2077.
14. Cooke, A., P. Tonks, F. M. Jones, H. O'Shea, P. Hutchings, A. J. Fulford, and D. W. Dunne. 1999. Infection with Schistosoma mansoni prevents insulin dependent diabetes mellitus in non-obese diabetic mice. Parasite Immunol. 21:169.
15. Bras, A., and A. P. Aguas. 1996. Diabetes-prone NOD mice are resistant to Mycobacterium avium and the infection prevents autoimmune disease. Immunology 89:20.
16. Akira, S., K. Takeda, and T. Kaisho. 2001. Toll-like receptors: Critical proteins linking innate and acquired immunity. Nat. Immunol. 2:675.
17. Sai, P., and A. S. Rivereau. 1996. Prevention of diabetes in the nonobese diabetic mouse by oral immunological treatments: Comparative efficiency of human insulin and two bacterial antigens, lipopolysaccharide from Escherichia coli and glycoprotein extract from Klebsielia pneumoniae. Diabetes Metab. 22:341.
18. Tian, J., D. Zekzer, L. Hanssen, Y. Lu, A. Olcott, and D. L. Kaufman. 2001. Lipopolysaccharide-activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice. J. Immunol. 167:1081.
19. Quintana, F. J., A. Rotem, P. Carmi, and I. R. Cohen. 2000. Vaccination with empty plasmid DNA or CpG oligonucleotide inhibits diabetes in nonobese diabetic mice: Modulation of spontaneous 60-kDa heat shock protein autoimmunity. J. Immunol. 165:6148.
20. Ablamunits, V., F. Quintana, T. Reshef, D. Elias, and I. R. Cohen. 1999. Acceleration of autoimmune diabetes by cyclophosphamide is associated with an enhanced IFN-gamma; secretion pathway. J. Autoimmun. 13:383.
21. Yasunami, R., and J. F. Bach. 1988. Anti-suppressor effect of cyclophosphamide on the development of spontaneous diabetes in NOD mice. Eur. J. Immunol. 18:481.
22. Atkinson, M. A., and E. H. Leiter. 1999. The NOD mouse model of type I diabetes: As good as it gets? Nat. Med. 5:601.
23. Maron, R., M. Guerau-de-Arellano, X. Zhang, and H. L. Weiner. 2001. Oral administration of insulin to neonates suppresses spontaneous and cyclophosphamide induced diabetes in the NOD mouse. J. Autoimmun. 16:21.
24. Charlton, B., C. Taylor-Edwards, R. Tisch, and C. G. Fathman. 1994. Prevention of diabetes and insulitis by neonatal intrathymic islet administration in NOD mice. J. Autoimmun. 7:549.
25. Qin, H. Y., and B. Singh. 1997. BCG vaccination prevents insulin-dependent diabetes mellitus (IDDM) in NOD mice after disease acceleration with cyclophosphamide. J. Autoimmun. 10:271.
26. Quinn, A., B. McInerney, E. P. Reich, O. Kim, K. P. Jensen, and E. E. Sercarz. 2001. Regulatory and effector CD4 T cells in nonobese diabetic mice recognize overlapping determinants on glutamic acid decarboxylase and use distinct V beta genes. J. Immunol. 166:2982.
27. Sai, P., A. S. Rivereau, C. Granier, T. Haertle, and L. Martignat. 1996. Immunization of non-obese diabetic (NOD) mice with glutamic acid decarboxylasederived peptide 524-543 reduces cyclophosphamide-accelerated diabetes. Clin. Exp. Immunol. 105:330.
28. Garren, H., and L. Steinman. 2000. DNA vaccination in the treatment of autoimmune disease. Curr. Dir. Autoimmun. 2:203.
29. Tascon, R. E., M. J. Colston, S. Ragno, E. Stavropoulos, D. Gregory, and D. B. Lowrie. 1996. Vaccination against tuberculosis by DNA injection. Nat. Med. 2:888.
30. Bockova, J., D. Elias, and I. R. Cohen. 1997. Treatment of NOD diabetes with a novel peptide of the hsp60 molecule induces Th2-type antibodies. J. Autoimmun. 10:323.
31. Vabulas, R. M., P. Ahmad-Nejad, C. da Costa, T. Miethke, C. J. Kirschning, H. Hacker, and H. Wagner. 2001. Endocytosed hsp60s use toll-like receptor 2 (TLR2) and TLR4 to activate the Toll/interleukin-I receptor signaling pathway in innate immune cells. J. Biol. Chem. 276:31332.
32. Hemmi, H., O. Takeuchi, T. Kawai, T. Kaisho, S. Sato, H. Sanjo, M. Matsumoto, K. Hoshino, H. Wagner, K. Takeda, and S. Akira. 2000. A Toll-like receptor recognizes bacterial DNA. Nature 408:740.
33. Tian, J., and D. L. Kaufman. 1998. Attenuation of inducible Th2 immunity with autoimmune disease progression. J. Immunol. 161:5399.
34. Tian, J., P. V. Lehmann, and D. L. Kaufman. 1997. Determinant spreading of T helper cell 2 (Th2) responses to pancreatic islet autoantigens. J. Exp. Med. 186:2039.
35. Raz, I., D. Elias, A. Avron, M. Tamir, M. Metzger, and I. R. Cohen. 2001. β-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): a randomised, double-blind, Phase II trial. Lancet 358:1749.
36. Tisch, R., B. Wang, M. A. Atkinson, D. V. Serreze, and R. Friedline. 2001. A glutamic acid decarboxylase 65-specific Th2 cell clone immunoregulates autoimmune diabetes in nonobese diabetic mice. J. Immunol. 166:6925.
37. Serreze, D. V., H. D. Chapman, C. M. Post, E. A. Johnson, W. L. Suarez-Pinzon, and A. Rabinovitch. 2001. Th1 to Th2 cytokine shifts in nonobese diabetic mice: Sometimes an outcome, rather than the cause of diabetes resistance elicited by immunostimulation. J. Immunol. 166:1352.